Security readout for executives and security teams
Plain-English summary
CVE-2017-1354 is a cross-site scripting issue in IBM Atlas eDiscovery Process Management. A user could place JavaScript into the web interface, potentially changing what trusted users see or exposing credentials during a session. The bundle does not provide CVSS scoring or confirmed exploitation.
Executive priority
Treat this as a targeted remediation item for legacy IBM eDiscovery environments. It is not supported as actively exploited by the supplied sources, but credential exposure inside trusted legal or discovery workflows can create meaningful business risk.
Technical view
IBM reports that Atlas eDiscovery Process Management 6.0.3 and listed 6.0.3.x versions allow arbitrary JavaScript embedding in the Web UI. The described impact is altered UI functionality and possible credential disclosure within a trusted session. No CWE, CVSS vector, or concrete remediation version is included in the supplied bundle.
Likely exposure
Exposure is likely limited to organizations still running IBM Atlas eDiscovery Process Management 6.0.3, 6.0.3.2, 6.0.3.3, 6.0.3.4, or 6.0.3.5, especially where untrusted or lower-privileged users can access the Web UI.
Exploitation context
The bundle does not indicate active exploitation, and CVE is not listed as KEV. The issue requires a path to place JavaScript in the application UI and a trusted user session where that script can run.
Researcher notes
Evidence is sparse: the bundle identifies affected versions and XSS impact but lacks CVSS, CWE, endpoint details, exploit maturity, and patch version text. Avoid assuming exploitability beyond authenticated or authorized Web UI content injection unless IBM advisory details confirm more.
Mitigation direction
- Check IBM advisory guidance for fixed versions or vendor-supported mitigations.
- Prioritize upgrade or remediation for internet-accessible or broadly accessible deployments.
- Restrict Web UI access to trusted users until vendor guidance is applied.
- Review application content for unexpected script-like input or UI tampering indicators.
Validation and detection
- Inventory IBM Atlas eDiscovery Process Management instances and record exact versions.
- Confirm whether any listed 6.0.3.x affected versions are deployed.
- Review IBM support advisory for remediation status and applicable fixed builds.
- Check access controls around the Web UI and who can submit content.
Public sources used
Generated from the cited source records. This long-tail analysis has not been individually reviewed by a named human.
Conservative CVE-to-ATT&CK context
These mappings and lookup hints may be relevant to the vulnerability behavior, CWE, affected product, or exposure path. Glexia-inferred context is not an official MITRE, ATT&CK, CWE, or CVE Program mapping.
ATT&CK lookup starting points
Use these exact CWE pages and searches to review the Glexia ATT&CK library from this CVE's weakness and description context.
CVE-2017-1354 mapping review
Open the CVE-to-ATT&CK bridge for reviewed, inferred, or future official mappings tied to this CVE.
Open ATT&CK lookup- Severity
- Unknown
- CVSS
- Not scored
- Known Exploited
- No
- Published
CNA and ADP enrichment extracted from CVE v5
These fields come from the CVE record and ADP containers, not from Glexia's Take. They preserve time-varying source decisions such as CISA SSVC, KEV status, CVSS metrics, and provider references.
CVSS and timeline data
No CVSS vectors or timeline events were available in the normalized CVE source material.
Source materials
- CVE List V5 sourceCVE List V5
- https://exchange.xforce.ibmcloud.com/vulnerabilities/126681CVE reference · x_refsource_MISC
- https://www.ibm.com/support/docview.wss?uid=swg22005828CVE reference · x_refsource_CONFIRM
Products and packages named in the record
CWE details
CWE links open Glexia weakness intelligence pages with official CWE context, developer remediation guidance, and related CVE mappings.